Advancements lead to a new trial involving autoimmune disease
Two thirds of patients responded to CAR T-cell therapy
Dispelling myths and sharing practical experiences
Autologous anti-CD19 agent produces impressive survival improvements
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A highly innovative treatment process for young people